Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and long term risks of the new companies….. A full-service firm!
It was a banner week for the IPO market as five deals came to market with an average gain of 29.8% at first trade.
It turned out that there were many candidates for ‘deal-of-the-week’ but DocuSign Inc (DOCU) took home the title in terms of points opened vs. pricing. DOCU was priced at $29.00…and opened for a first trade of $38.00 for a gain of 31.0% at first trade.
The IPO that performed the best in terms of percentage gains was nLIGHT Inc (LASR). LASR was upsized and priced at $16.00 — $1.00 above the $13-$15 range. The IPO was met with outstanding demand in the aftermarket as it opened for a first trade at $23.00 for a gain of 43.8% and hit a first day high of $28.30 as the stock spiked to close out its initial session.
The other two technology offerings of the week, Ceridian HCM Solutions (CDAY) and Smartsheet Inc (SMAR) each priced $1.00 above range. CDAY priced 21.0mm shares at $22.00 and opened 31.4% higher with a first trade of $28.90. SMAR upwardly-revised its range and priced $1.00 above that at $15.00 and opened at $18.40. The “surprise” of the week was
Goosehead Insurance (GSHD) which came to market successfully but only after pricing its IPO $5.00 in the hole. Goosehead priced 8.5mm shares at $10.00 and opened with a 20% premium. GSHD traded extremely-well in its initial session and traded to a high of $17.54 (75.4% above IPO px) before retreating to end the session at $15.75. This IPO also marks the first deal to come at a premium after the eight previous deals that priced below range either opened flat or in the red.
It should be noted that Taiwan Liposome (TLC) did not price as anticipated. The underwriter has stated that the deal is in ‘day-to-day’ status. There is no further information at this time.
Looking ahead to this week, there are eight IPOs on the schedule.
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish